Responses
Poster Presentation
Adaptative immunity (T cells and B cells) in rheumatic diseases & innate immunity in rheumatic diseases
THU0029 Epratuzumab Influences BCR Signalling on TLR9 Pre-Activated B Cells by Targeting CD22
Compose a Response to This Article
Other responses
No responses have been published for this article.